These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 27773883)

  • 1. Experimental infections using the foot-and-mouth disease virus O/JPN/2010 in animals administered a vaccine preserved for emergency use in Japan.
    Fukai K; Nishi T; Shimada N; Morioka K; Yamada M; Yoshida K; Sakamoto K; Kitano R; Yamazoe R; Yamakawa M
    J Vet Med Sci; 2017 Jan; 79(1):128-136. PubMed ID: 27773883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of doubled dose administration of foot-and-mouth disease vaccine against heterologous virus infection in cattle.
    Kawaguchi R; Nishi T; Fukai K; Ikezawa M; Kokuho T; Morioka K
    J Vet Med Sci; 2024 Jul; 86(7):777-786. PubMed ID: 38719616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Malaysia 97 monovalent foot-and-mouth disease vaccine (>6PD50/dose) protects pigs against challenge with a variant FMDV A SEA-97 lineage virus, 4 and 7 days post vaccination.
    Nagendrakumar SB; Hong NT; Geoffrey FT; Jacqueline MM; Andrew D; Michelle G; Van Phuc K; Ngon QV; Phuong le TT; Phuc NN; Hanh TX; Van Hung V; Quynhanh le T; Tan TM; Long NT; Wilna V
    Vaccine; 2015 Aug; 33(36):4513-9. PubMed ID: 26192355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A foot-and-mouth disease SAT2 vaccine protects swine against experimental challenge with a homologous virus strain, irrespective of mild pathogenicity in this species.
    Mouton L; Dekker A; Bleijenberg M; Blanchet M; Coco-Martin J; Hudelet P; Goutebroze S
    Vaccine; 2018 Apr; 36(15):2020-2024. PubMed ID: 29510916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination.
    Wilna V; Hong NT; Geoffrey FT; Jacqueline MM; Jianning W; Van Phuc K; Ngon QV; Phuong le TT; Hung D; Hanh TX; Van Hung V; Anh le TQ; Tien MT; Quang le TV; Long NT; Nagendrakumar SB
    Vaccine; 2015 Jun; 33(24):2778-85. PubMed ID: 25917677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.
    Eblé PL; Bouma A; Weerdmeester K; Stegeman JA; Dekker A
    Vaccine; 2007 Jan; 25(6):1043-54. PubMed ID: 17157418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of emergency foot-and-mouth disease (FMD) vaccines.
    Barnett PV; Carabin H
    Vaccine; 2002 Feb; 20(11-12):1505-14. PubMed ID: 11858856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C).
    Cao Y; Lu Z; Li D; Fan P; Sun P; Bao H; Fu Y; Li P; Bai X; Chen Y; Xie B; Liu Z
    Vet Microbiol; 2014 Jan; 168(2-4):294-301. PubMed ID: 24345411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient protection against Asia1 type foot-and-mouth disease using a chimeric vaccine strain suitable for East Asia.
    Ko MK; Jo HE; Choi JH; You SH; Shin SH; Hwang SY; Jo H; Kim HM; Lee MJ; Kim SM; Kim B; Park JH
    Vet Microbiol; 2021 Feb; 253():108975. PubMed ID: 33418393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses in pigs and cattle vaccinated with half-volume foot-and-mouth disease vaccine.
    Park ME; You SH; Lee SY; Lee KN; Ko MK; Choi JH; Kim B; Lee JS; Park JH
    J Vet Sci; 2017 Aug; 18(S1):323-331. PubMed ID: 28859272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses of pigs to commercialized emulsion FMD vaccines and live virus challenge.
    Chen SP; Lee MC; Sun YF; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR; Ellis TM
    Vaccine; 2007 May; 25(22):4464-9. PubMed ID: 17445957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
    Schutta C; Barrera J; Pisano M; Zsak L; Grubman MJ; Mayr GA; Moraes MP; Kamicker BJ; Brake DA; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2016 Jun; 34(27):3214-3220. PubMed ID: 26707216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cedivac-FMD can be used according to a marker vaccine principle.
    Chénard G; Selman P; Dekker A
    Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ; Muller JD; Yu M; Wang LF; Heine HG
    J Immunol Methods; 2007 Apr; 321(1-2):142-51. PubMed ID: 17328909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model.
    Neilan JG; Schutta C; Barrera J; Pisano M; Zsak L; Hartwig E; Rasmussen MV; Kamicker BJ; Ettyreddy D; Brough DE; Butman BT; Brake DA
    BMC Vet Res; 2018 Aug; 14(1):254. PubMed ID: 30157853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased humoral antibody response of foot-and-mouth disease virus vaccine in growing pigs pre-treated with poly-γ-glutamic acid.
    Lee JH; Kang IJ; Kim AR; Noh YS; Chung HC; Park BK
    J Vet Sci; 2016 Jun; 17(2):253-6. PubMed ID: 26645341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of guinea pigs and swine by a recombinant adenovirus expressing O serotype of foot-and-mouth disease virus whole capsid and 3C protease.
    Lu Z; Bao H; Cao Y; Sun P; Guo J; Li P; Bai X; Chen Y; Xie B; Li D; Liu Z; Xie Q
    Vaccine; 2008 Dec; 26 Suppl 6():G48-53. PubMed ID: 19178894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of foot-and-mouth disease (FMD) virus load in nasal excretions, saliva and exhaled air of vaccinated pigs following direct contact challenge.
    Parida S; Fleming L; Oh Y; Mahapatra M; Hamblin P; Gloster J; Doel C; Gubbins S; Paton DJ
    Vaccine; 2007 Nov; 25(45):7806-17. PubMed ID: 17920730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a peptide-based immunochromatographic strip for differentiation of serotype O Foot-and-mouth disease virus-infected pigs from vaccinated pigs.
    Yang S; Yang J; Zhang G; Qiao S; Wang X; Zhao D; Li X; Deng R; Zhi A; You L; Chai S; Teng M
    J Vet Diagn Invest; 2010 May; 22(3):412-5. PubMed ID: 20453216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.